Extract: It is generally accepted that women with breast cancer (BC) have an increased risk of venous thromboembolism (VTE) compared with women of matching age, but no cancer. Metastatic disease, chemotherapy and tamoxifen treatment are all risk factors for increased VTE risk. Particularly, a 6% annual VTE incidence while undergoing chemotherapy, and up to one month after, has been recently reported in a cohort study, showing that VTE risk was markedly higher in the 3 months after initiation of tamoxifen, but not aromatase inhibitors ...
Ferroni, P., Roselli, M., Riondino, S., Cavaliere, F., Guadagni, F. (2016). Insulin resistance as a predictor of venous thromboembolism in breast cancer. ENDOCRINE-RELATED CANCER, ERC-16-0187 [10.1530/ERC-16-0187].
Insulin resistance as a predictor of venous thromboembolism in breast cancer
ROSELLI, MARIO;Riondino, S;
2016-05-16
Abstract
Extract: It is generally accepted that women with breast cancer (BC) have an increased risk of venous thromboembolism (VTE) compared with women of matching age, but no cancer. Metastatic disease, chemotherapy and tamoxifen treatment are all risk factors for increased VTE risk. Particularly, a 6% annual VTE incidence while undergoing chemotherapy, and up to one month after, has been recently reported in a cohort study, showing that VTE risk was markedly higher in the 3 months after initiation of tamoxifen, but not aromatase inhibitors ...I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
